Publikationen 2006

1. Mueller T, Haltmayer M. Natriuretic peptide measurements as part of the diagnostic work-up in pleural effusions: an emerging concept? Eur Resp J 2006;28:7-9. [PubMed]

2. Dieplinger B, Poelz W, Haltmayer M, Mueller T. Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease. Clin Chem Lab Med 2006;44:830-3. [PubMed]

3. Mueller T, Dieplinger B, Poelz W, Haltmayer M. Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease study. Clin Chem 2006;52:1096-103. [PubMed]

4. Gegenhuber A, Mueller T, Dieplinger B, Poelz W, Pacher R, Haltmayer M. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clin Chim Acta 2006;370:174-9. [PubMed]

5. Gegenhuber A, Struck J, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T. Utility of mid-regional pro-A-type natriuretic peptide measurements for the diagnosis of acute destabilized heart failure in short-of-breath patients presenting to an emergency department: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clin Chem 2006;52:827-31. [PubMed]